Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group. (28th November 2019)
- Record Type:
- Journal Article
- Title:
- Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group. (28th November 2019)
- Main Title:
- Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group
- Authors:
- Lafarge, Antoine
Joseph, Adrien
Pagnoux, Christian
Puéchal, Xavier
Cohen, Pascal
Samson, Maxime
Hamidou, Mohamed
Karras, Alexandre
Quemeneur, Thomas
Ribi, Camillo
Groh, Matthieu
Mouthon, Luc
Guillevin, Loïc
Terrier, Benjamin - Abstract:
- Abstract: Objectives: Infections remain a major cause of morbidity and mortality in systemic necrotizing vasculitides (SNV). We aimed to identify factors predicting severe infections (SI) in SNV. Methods: Data from five randomized controlled trials (RCTs) enrolling 733 patients were pooled. The primary end point was the occurrence of SI, defined by the need of a hospitalization and/or intravenous anti-infectious treatment and/or leading to death. Results: After a median follow-up of 5.2 (interquartile range 3–9.7) years, 148 (20.2%) patients experienced 189 SI, and 98 (66.2%) presented their first SI within the first 2 years. Median interval from inclusion to SI was 14.9 (4.3–51.7) months. Age ≥65 years (hazard ratio (HR) 1.49 [1.07–2.07]; P =0.019), pulmonary involvement (HR 1.82 [1.26–2.62]; P =0.001) and Five Factor Score ≥1 (HR 1.21 [1.03–1.43]; P =0.019) were independent predictive factors of SI. Regarding induction therapy, the occurrence of SI was associated with the combination of GCs and CYC (HR 1.51 [1.03–2.22]; P = 0.036), while patients receiving only GCs were less likely to present SI (HR 0.69 [0.44–1.07]; P = 0.096). Finally, occurrence of SI had a significant negative impact on survival ( P <0.001). Conclusion: SI in SNV are frequent and impact mortality. Age, pulmonary involvement and Five Factor Score are baseline independent predictors of SI. No therapeutic regimen was significantly associated with SI but patients receiving glucocorticoids and CYC asAbstract: Objectives: Infections remain a major cause of morbidity and mortality in systemic necrotizing vasculitides (SNV). We aimed to identify factors predicting severe infections (SI) in SNV. Methods: Data from five randomized controlled trials (RCTs) enrolling 733 patients were pooled. The primary end point was the occurrence of SI, defined by the need of a hospitalization and/or intravenous anti-infectious treatment and/or leading to death. Results: After a median follow-up of 5.2 (interquartile range 3–9.7) years, 148 (20.2%) patients experienced 189 SI, and 98 (66.2%) presented their first SI within the first 2 years. Median interval from inclusion to SI was 14.9 (4.3–51.7) months. Age ≥65 years (hazard ratio (HR) 1.49 [1.07–2.07]; P =0.019), pulmonary involvement (HR 1.82 [1.26–2.62]; P =0.001) and Five Factor Score ≥1 (HR 1.21 [1.03–1.43]; P =0.019) were independent predictive factors of SI. Regarding induction therapy, the occurrence of SI was associated with the combination of GCs and CYC (HR 1.51 [1.03–2.22]; P = 0.036), while patients receiving only GCs were less likely to present SI (HR 0.69 [0.44–1.07]; P = 0.096). Finally, occurrence of SI had a significant negative impact on survival ( P <0.001). Conclusion: SI in SNV are frequent and impact mortality. Age, pulmonary involvement and Five Factor Score are baseline independent predictors of SI. No therapeutic regimen was significantly associated with SI but patients receiving glucocorticoids and CYC as induction tended to have more SI. … (more)
- Is Part Of:
- Rheumatology. Volume 59:Number 9(2020)
- Journal:
- Rheumatology
- Issue:
- Volume 59:Number 9(2020)
- Issue Display:
- Volume 59, Issue 9 (2020)
- Year:
- 2020
- Volume:
- 59
- Issue:
- 9
- Issue Sort Value:
- 2020-0059-0009-0000
- Page Start:
- 2250
- Page End:
- 2257
- Publication Date:
- 2019-11-28
- Subjects:
- vasculitis -- severe infection -- glucocorticoids -- rituximab -- immunosuppressive agents
Rheumatism -- Periodicals
Rheumatology -- Periodicals
616.723005 - Journal URLs:
- http://rheumatology.oupjournals.org ↗
http://rheumatology.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1093/rheumatology/kez575 ↗
- Languages:
- English
- ISSNs:
- 1462-0324
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7960.731900
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15132.xml